Pablo Granados-Durán

Pablo Granados-Durán

Auto-generated profile, based on publicly available information

Pablo Granados-Durán

Laboratory of Neurobiology, Centro de Investigaciones Medico Sanitaria (CIMES), University of Malaga, Malaga, Spain

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2012 in Histochemistry and Cell Biology
Verified
Journal Article
Closed access
PDF file
Jesús Mateos GrondonaJesús Mateos Grondona
Jesús Mateos Grondona
PGP. Granados-Durán
P. Granados-Durán
PFP. Fernández-Llebrez
P. Fernández-Llebrez
María Dolores López ÁvalosMaría Dolores López Ávalos
María Dolores López Ávalos

17 March 2015 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
PGPablo Granados-Durã¡N
Pablo Granados-Durã¡N
MLMarã­a D. Lã³Pez-Ãvalos
Marã­a D. Lã³Pez-Ãvalos
Jesús Mateos GrondonaJesús Mateos Grondona
Jesús Mateos Grondona
MGMarã­a del Carmen Gã³Mez-Roldã¡N
Marã­a del Carmen Gã³Mez-Roldã¡N
MCManuel Cifuentes
Manuel Cifuentes
PFPedro Fernã¡Ndez-Llebrez
Pedro Fernã¡Ndez-Llebrez
In the present paper we describe the facts that took place in the rat brain after a single injection of the enzyme neuraminidase from Clostridium perfringens into the right lateral ventricle. After injection, it diffused through the cerebrospinal fluid of the ipsilateral ventricle and the third ventricle, and about 400 µm into the periventricular brain parenchyma. The expression of ICAM1 in the endothelial cells of the periventricular vessels, IBA1 in microglia, and GFAP in astrocytes notably increased in the regions reached by the injected neuraminidase. The subependymal microglia and the ventricular macrophages begun to express IL1β and some appeared to cross the ependymal layer. After about 4 hours of the injection, leukocytes migrated from large venules of the affected choroid plexus, the meninges and the local subependyma, and infiltrated the brain. The invading cells arrived orderly: first neutrophils, then macrophage-monocytes, and last CD8α-positive T-lymphocytes and B-lymphocytes. Leukocytes in the ventricles and the perivascular zones penetrated the brain parenchyma passing through the ependyma and the glia limitans. Thus it is likely that a great part of the damage produced by microorganism invading the brain may be due to their neuraminidase content.

12 August 2011 in Journal of Neuroscience Methods
Verified
Journal Article
Closed access
MCManuel Cifuentes
Manuel Cifuentes
MPMargarita Pérez-Martín
Margarita Pérez-Martín
Jesús Mateos GrondonaJesús Mateos Grondona
Jesús Mateos Grondona
MLM.D. López-Ávalos
M.D. López-Ávalos
NINobuya Inagaki
Nobuya Inagaki
PFP. Fernández-Llebrez
P. Fernández-Llebrez

21 May 2016 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
PGPablo Granados-Durán
Pablo Granados-Durán
MLMaría Dolores López-Ávalos
María Dolores López-Ávalos
THTimothy R. Hughes
Timothy R. Hughes
KJKrista Johnson
Krista Johnson
BMB Paul Morgan
B Paul Morgan
Jesús Mateos GrondonaJesús Mateos Grondona
Jesús Mateos Grondona
In the rat brain, a single intracerebroventricular injection of neuraminidase from Clostridium perfringens induces ependymal detachment and death. This injury occurs before the infiltration of inflammatory blood cells; some reports implicate the complement system as a cause of these injuries. Here, we set out to test the role of complement. The assembly of the complement membrane attack complex on the ependymal epithelium of rats injected with neuraminidase was analyzed by immunohistochemistry. Complement activation, triggered by neuraminidase, and the participation of different activation pathways were analyzed by Western blot. In vitro studies used primary cultures of ependymal cells and explants of the septal ventricular wall. In these models, ependymal cells were exposed to neuraminidase in the presence or absence of complement, and their viability was assessed by observing beating of cilia or by trypan blue staining. The role of complement in ependymal damage induced by neuraminidase was analyzed in vivo in two rat models of complement blockade: systemic inhibition of C5 by using a function blocking antibody and testing in C6-deficient rats. The complement membrane attack complex immunolocalized on the ependymal surface in rats injected intracerebroventricularly with neuraminidase. C3 activation fragments were found in serum and cerebrospinal fluid of rats treated with neuraminidase, suggesting that neuraminidase itself activates complement. In ventricular wall explants and isolated ependymal cells, treatment with neuraminidase alone induced ependymal cell death; however, the addition of complement caused increased cell death and disorganization of the ependymal epithelium. In rats treated with anti-C5 and in C6-deficient rats, intracerebroventricular injection of neuraminidase provoked reduced ependymal alterations compared to non-treated or control rats. Immunohistochemistry confirmed the absence of membrane attack complex on the ependymal surfaces of neuraminidase-exposed rats treated with anti-C5 or deficient in C6. These results demonstrate that the complement system contributes to ependymal damage and death caused by neuraminidase. However, neuraminidase alone can induce moderate ependymal damage without the aid of complement.

31 July 2019 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MMMariam Masmudi‐Martin
Mariam Masmudi‐Martin
ILIrene Navarro Lobato
Irene Navarro Lobato
MLManuel F. López-Aranda
Manuel F. López-Aranda
GDGloria Delgado
Gloria Delgado
EMElisa Martín-Montañez
Elisa Martín-Montañez
ZKZafaruddin Khan
Zafaruddin Khan
Memory deficits affect a large proportion of the human population and are associated with aging and many neurologic, neurodegenerative, and psychiatric diseases. Treatment of this mental disorder has been disappointing because all potential candidates studied thus far have failed to produce consistent effects across various types of memory and have shown limited to no effects on memory deficits. Here, we show that the promotion of neuronal arborization through the expression of the regulator of G‐protein signaling 14 of 414 amino acids (RGS14 414 ) not only induced robust enhancement of multiple types of memory but was also sufficient for the recovery of recognition, spatial, and temporal memory, which are kinds of episodic memory that are primarily affected in patients or individuals with memory dysfunction. We observed that a surge in neuronal arborization was mediated by up‐regulation of brain‐derived neurotrophic factor (BDNF) signaling and that the deletion of BDNF abrogated both neuronal arborization activation and memory enhancement. The activation of BDNF‐dependent neuronal arborization generated almost 2‐fold increases in synapse numbers in dendrites of pyramidal neurons and in neurites of nonpyramidal neurons. This increase in synaptic connections might have evoked reorganization within neuronal circuits and eventually supported an increase in the activity of such circuits. Thus, in addition to showing the potential of RGS14 414 for rescuing memory deficits, our results suggest that a boost in circuit activity could facilitate memory enhancement and the reversal of memory deficits.—Masmudi‐Martín, M., Navarro‐Lobato, I., López‐Aranda, M. F., Delgado, G., Martín‐Montañez, E., Quiros‐Ortega, M. E., Carretero‐Rey, M., Narváez, L., Garcia‐Garrido, M. F., Posadas, S., López‐Téllez, J. F., Blanco, E., Jiménez‐Recuerda, I., Granados‐Durán, P., Paez‐Rueda, J., López, J. C., Khan, Z. U. RGS14 414 treatment induces memory enhancement and rescues episodic memory deficits. FASEB J. 33, 11804‐11820 (2019). www.fasebj.org